What is Orthopediatrics Corp (KIDS) stock price today?

Orthopediatrics Corp (KIDS) currently trades at $15.06 per share. The stock has a market capitalization of $406.36M and a P/E ratio of —x.

Is KIDS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Orthopediatrics Corp has a Smart Value Score of 38/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Orthopediatrics Corp's revenue and earnings?

Orthopediatrics Corp has trailing twelve-month (TTM) revenue of $236.35M with profit margins of -16.80%. Earnings per share (EPS) is $-1.69.

Is KIDS stock overvalued or undervalued?

Based on our DCF model, Orthopediatrics Corp's intrinsic value is $74.10, representing a margin of safety of 76.76%. The stock currently trades at a P/E of —x.

KIDS

Orthopediatrics Corp

NASDAQ: KIDS · HEALTHCARE · MEDICAL DEVICES

$15.06

+2.87% today

Updated 2026-04-30

Market cap

$406.36M

P/E ratio

—

P/S ratio

1.72x

EPS (TTM)

$-1.69

Dividend yield

—

52W range

$15 – $24

Volume

0.2M

Market cap

$406.36M

P/E ratio

—

P/S ratio

1.72x

EPS (TTM)

$-1.69

Dividend yield

—

52W range

$15 – $24

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$25.00

+66.00%

12-Month target

—

Intrinsic (DCF)

$74.10

Margin of safety

+76.76%

3 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $9.75M — positive

+ Revenue growth 17.00% QoQ

+ 76.76% below intrinsic value

Risks

- Thin margins at -16.80%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$122.29M	$148.73M	$204.73M	$236.35M	$236.35M
Net income	$1.26M	$-20.97M	$-37.82M	$-39.65M	$-10.10M
EPS	—	—	—	—	$-1.69
Free cash flow	$-31.80M	$-46.03M	$-41.31M	$-15.96M	$9.75M
Profit margin	1.03%	-14.10%	-18.47%	-16.78%	-16.80%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-16	ODLE, GREGORY A	Sale	8,433	$17.25
2026-03-16	HITE, FRED	Sale	12,993	$17.25
2026-03-16	HAUSER, JOSEPH W	Sale	8,596	$17.25

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KIDS	$406.36M	38	7.3	2.0	6.7	5.0	+76.76%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Orthopediatrics Corp trades at $15.06. Our Smart Value Score of 38/100 indicates the stock is weak. TTM revenue stands at $236.35M. with profit margins at -16.80%. Our DCF model estimates intrinsic value at $74.10.

Frequently asked questions

What is Orthopediatrics Corp's stock price?

Orthopediatrics Corp (KIDS) trades at $15.06.

Is Orthopediatrics Corp overvalued?

Smart Value Score 38/100 (Grade D, Sell). DCF value $74.10.

What is the price target of Orthopediatrics Corp (KIDS)?

The analyst target price is $25.00, representing +66.0% upside from the current price of $15.06.

What is the intrinsic value of Orthopediatrics Corp (KIDS)?

Based on our DCF model, intrinsic value is $74.10, a +76.8% margin of safety versus $15.06.

What is Orthopediatrics Corp's revenue?

TTM revenue is $236.35M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.72x

ROE-11.30%

Beta1.16

50D MA$16.87

200D MA$18.23

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week-3.36%

1 month+4.08%

3 months-8.66%

YTD-10.92%

1 year—

3 years—

5 years—

Compare

KIDS vs LLY →KIDS vs JNJ →KIDS vs ABBV →Stock screener →